Skip to main content
AJNR: American Journal of Neuroradiology logoLink to AJNR: American Journal of Neuroradiology
. 2011 Apr;32(4):654–657. doi: 10.3174/ajnr.A2368

Asymptomatic and Unrecognized Cement Pulmonary Embolism Commonly Occurs with Vertebroplasty

MT Luetmer b, BJ Bartholmai a,b, AE Rad a,b, DF Kallmes b,
PMCID: PMC7965890  PMID: 21415145

Abstract

BACKGROUND AND PURPOSE:

Cement PE represents a potentially serious complication following vertebroplasty. To determine the frequency and extent of cement PE during percutaneous vertebroplasty, we performed a retrospective review of chest CT scans obtained in patients who had previously undergone ≥1 vertebroplasty procedure.

MATERIALS AND METHODS:

After approval by our local institutional review board, we retrospectively evaluated 244 patients who had undergone vertebroplasty at 465 levels and subsequently underwent chest CT. A thoracic radiologist evaluated the presence, number, size, and location of discrete cement PEs. We catalogued the following data: age, sex, number of treated vertebrae, cement volume per vertebra, operator, presence of cement leakage noted by the operator during the procedure, and clinical presentation at postvertebroplasty CT.

RESULTS:

At least 1 cement PE was detected in 23 (9.4%; 95% CI, 6%–13%) of 244 patients; 1 patient was symptomatic from a cement PE. The mean number of discrete cement PEs was 3.2 ± 3.4 (median, 2; range, 1–12). There was no correlation among the total number of treatment sessions, number of levels treated per session, cement volume per level, operator, or time between vertebroplasty and chest CT in the detection of cement PE. Those with PE were significantly younger (P = .0229) and had significantly more total levels treated (P = .0260). Cement PE was recognized by the operator during the vertebroplasty in 2 (8.7%) of 23 patients found to have it on CT.

CONCLUSIONS:

Small asymptomatic cement PEs are common during vertebroplasty and usually are not recognized by the operator during the procedure.


Percutaneous vertebroplasty is a widely applied treatment for symptomatic vertebral compression fractures. A potentially serious complication of vertebroplasty is the leakage of PMMA bone cement outside the vertebral body, which then leads to cement PE.14 To better define the incidence of PE associated with vertebroplasty, we performed a retrospective review of chest CT scans obtained in patients who had previously undergone ≥1 vertebroplasty procedure.

Materials and Methods

The study was approved by our local institutional review board. This retrospective study surveyed a data base of 1029 consecutive clinical patients, excluding those enrolled in prospective research trials, who had undergone a total of 1247 vertebroplasty procedures between February 4, 1999, and June 3, 2010. A number of previous case series from our institution have been published by using a portion of this same patient data base.528 However, we have neither previously performed a detailed analysis of the incidence of cement PE nor ever evaluated postprocedural chest CT findings in these patients. Among these 1029 patients, 250 (24%) subsequently underwent chest CT at our institution, usually for indications unrelated to the vertebroplasty. Six (2.4%) of these 250 patients underwent vertebroplasty outside our institution and were excluded, leaving 244 patients (23.7%) in the current study.

The chest CT technique varied depending on CT indication and date. CT examinations performed without IV contrast and those performed with only IV contrast were included. All examinations performed after April 2005 included 1.5-mm contiguous axial images. Before this date, the chest CT technique was not controlled for minimum section thickness. A single investigator performed a chart review of patient and procedural records to evaluate age, sex, number of treated vertebrae, cement volume per vertebra, operator, presence of cement leakage noted during the procedure by the operator, and presence or absence of pulmonary symptoms due to cement emboli. Operator-detected leakage was categorized as diskal, venous, paraspinal, and epidural.

A thoracic radiologist reviewed chest CT scans after each procedure to evaluate the presence, number, size, and location of cement PE in the pulmonary lobes on an independent diagnostic CT workstation in a darkened reading-room environment. Each CT series was viewed as a dynamic scrollable stack in multiple window/level settings, including standard soft-tissue, bone, lung, and a custom window/level setting designed to visualize high-attenuation barium-opacified PMMA in the presence of other IV contrast (approximately, window, 500; level, 450, adjusted manually for intravascular contrast intensity such that bright IV contrast was medium gray and PMMA was white). For each examination, axial 3D MIPs were used to maximize sensitivity to detect small emboli of PPMA, either MIPs produced routinely as part of the standard thoracic CT scan protocol (an approximately 15-mm-thick axial MIP slab reconstructed at 7-mm intervals) or those manually constructed on the independent workstation from the scan volume with the thinnest available set of images. In the case of patients who underwent multiple vertebroplasty procedures, chest CT performed after the final vertebroplasty session was reviewed.

Thirty-four (14%) patients had baseline chest CTs that were reviewed for comparison. We also assessed parenchymal changes associated with the cement emboli, and we noted any parenchymal changes adjacent or peripheral to the cement PEs. High-attenuation findings in the lungs were classified into 4 categories: certain (positive for cement PE), probable (likely cement but not definite), unlikely (most likely granuloma or other calcifications), and negative (high-attenuation structure in the lung confirmed not to be cement on the basis of historical comparisons). Calcifications smaller than the adjacent vessels associated with calcified lymph nodes in the expected drainage pattern, splenic/hepatic granulomas, or with typical clustered nodular densities were considered to be unlikely. For statistical comparisons, we defined the categories “certain” and “probable” as positive for cement PE, while categories “unlikely” and “negative” were considered negative for cement PE. Symptomatic patients were characterized as those presenting with respiratory symptoms within 30 days of vertebroplasty.

Percutaneous Vertebroplasty Technique

Details for typical vertebroplasty procedures at our institution have been published previously.17,18 Briefly, patients are usually treated under moderate sedation. Local anesthetic, consisting of subcutaneous 1% lidocaine and 0.25% bupivacaine, was placed into the deep soft tissues and periosteum with a 22-ga spinal needle. An 11- or 13-ga needle with an inner stylet was advanced under fluoroscopic guidance by using a transpedicular or parapedicular approach into the anterior one-third of the vertebral body in an attempt to reach the midline. Barium-opacified cement was typically infused under constant lateral fluoroscopy and intermittent anteroposterior fluoroscopy until it reached the posterior one-fourth of the vertebral body. The injection was terminated on observation of venous, epidural, paraspinal, or disk space extravasation. If the contralateral hemivertebral fill was inadequate, a second needle was placed into the contralateral side and additional cement was injected. The volume of cement used was recorded. Patients were instructed to remain supine for 2 hours postprocedure to allow hardening of the cement and resolution of sedation. Various cement mixtures without standardized PMMA-to-solvent ratios were used before July 2005. Since that time, Ava-Tex Radiopaque Bone Cement (Cardinal Health, Dublin, Ohio) has been used.

Statistics and Data Analysis

The frequency of the number and detection of cement PEs was analyzed as a proportion with 95% CIs. Patient age, total number of vertebroplasty sessions and levels treated, number of levels treated per session, cement volume per level, and time between vertebroplasty and CT were compared by using a t test. Operator-detected extraosseous leakage in patients with and without cement PE was compared by using a χ2 test.

Results

A total of 244 patients received treatment at 465 vertebral levels during 313 separate vertebroplasty sessions. Of these, 149 (61.1%) were women with a mean age of 71.4 ± 11.3 years; median, 73.9 years; range, 38.0–91.8 years. Ninety-five were men with a mean age of 68.2 ± 12.4 years; median, 71.0 years; range, 33.6–90.8 years. The age was listed at the time of the first vertebroplasty procedure. Eighty-two and eight-tenths percent (202/244) had 1 vertebroplasty session, 10.2% (25/244) had 2 vertebroplasty sessions, 5.3% (13/244) had 3 vertebroplasty sessions, and 1.6% (4/244) had ≥4 vertebroplasty sessions.

The average time between vertebroplasty and CT was 17.7 ± 21.1 months (median, 8.6 months; range, 0–99.4 months). Eighty-nine (36%) of 244 patients underwent CT for non-cement PE remote from the vertebroplasty, and 2 (0.8%) of 244 patients underwent CT specifically for cement PE. Other common indications were for chronic cough and shortness of breath, to evaluate pneumonitis or bronchiectasis, for metastatic cancer work-up, and to evaluate a pulmonary nodule or mass seen on chest radiographs. Non-IV contrast CT scans were available for review in 103 of 244 patients. The remaining 141 patients had only post-IV contrast images available.

Cement PEs were detected in 23 (9.4%; 95% CI, 6%–13%) of 244 patients. Of these, 87% (20/23) had certain cement PEs and 13% (3/23) had probable cement PEs. Fourteen of 23 patients (61%) underwent non-IV contrast CT, and 39% (9/23) had only post-IV contrast images available for review. One (4.3%; 95% CI, 0%–13%) of these 23 patients developed respiratory symptoms, manifested as mild dyspnea and left-sided pleuritic chest pain, which resolved gradually with conservative treatment. In this patient, who underwent a non-IV contrast CT, no parenchymal changes were visible. One asymptomatic patient (4.3%; 95% CI, 0%–13%) had parenchymal changes associated with the cement embolism visible on post-IV contrast CT.

Among these 23 patients with cement PEs, the mean number of discrete emboli per patient was 3.2 ± 3.4 (median, 2; range, 1–12). Nine (39%) of 23 patients had a single embolus, 6 (26%) had 2, three (13%) had 3 emboli, and 5 (22%) patients had 4–12 emboli. Most emboli were tubular or branching (Figs 1 and 2). The mean length of emboli was 5.0 ± 4.4 mm (median, 4.0 mm; range, 1–21 mm). Cement PEs were scattered throughout both upper and lower lobes of both lungs.

Fig 1.

Fig 1.

A 68-year-old woman treated with vertebroplasty at T12. Axial unenhanced chest CT scan obtained 4 months following vertebroplasty demonstrates linear areas of markedly increased attenuation (arrows) within the pulmonary vasculature, indicating cement PEs.

Fig 2.

Fig 2.

A 52-year-old man treated with vertebroplasty at L1, L2, L4, and T12. Axial contrast-enhanced chest CT image obtained 6 days following the third vertebroplasty procedure demonstrates linear areas of markedly increased attenuation (arrow) within the pulmonary vasculature, indicating cement PE.

There was no significant difference in the etiology of compression fractures treated in patients with and without cement PEs (P = .19). Of those 221 patients negative for cement PE, 116 (52%) had osteoporosis, 43 (19%) had trauma, 32 (14%) had malignancies, 26 (12%) had multiple myelomas, and 4 (2%) had an unknown etiology. Among these 23 patients with cement PEs, 16 (70%) had osteoporosis, 3 (13%) had a malignancy, 3 (13%) had multiple myelomas, and 1 (4%) had trauma.

As listed in the Table, we detected no significant difference between patients with and without cement PEs regarding total number of vertebroplasty sessions, number of levels treated per session, cement volume per level, operator, or time between vertebroplasty and CT. Those with cement PE were significantly younger than those without (P = .0229). Patients with cement PE had significantly more total levels treated (P = .0260). There was a trend toward a lower amount of cement used per level in the patients with cement PE compared with those without cement PE.

Statistical comparison of patients with and without cement PE

Positive for Cement PE Negative for Cement PE P Value
Total No. 23 221
Female 15 (65.2%) 134 (60.6%)
Male 8 (34.8%) 87 (39.4%)
Mean age (yr) 64.6 ± 11.6 70.7 ± 11.7 .0229
median, 65.0 median, 73.3
Total No. of levels treated 2.74 ± 1.8 1.8 ± 1.3 .0260
median, 2 median, 1
range, 1–7 range, 1–10
Total No. of sessions 1.61 ± 1.0 1.25 ± 0.8 .1029
median, 1 median, 1
range, 1–4 range, 1–9
No. of levels treated per session 1.75 ± 0.8 1.47 ± 0.7 .1129
median, 2, median, 1,
range, 1–4 range, 1–5
Cement volume per level (mL of PMMA) 2.74 ± 1.67 3.09 ± 1.43 .2212
median, 2.5 median, 3.0
range, 0.5–10 range, 0.3–10
Any type of extravasation noticed during procedure 37.8% 29.0% .27
(14/37 procedures) (80/276 procedures)
Venous extravasation noticed during procedure 18.9% 11.2% .41
(7/37 procedures) (31/276 procedures)
Mean time between vertebroplasty and CT (mo) 17.6 ± 23.9 17.8 ± 20.7 .9746

Operators detected extraosseous cement leakage in less than one-half of the 23 patients with cement PE (Table); such leakage was detected almost as frequently among patients without cement PE. Cement migration to the lungs was noticed by the operator during the vertebroplasty in 2 (8.7%) of 23 patients later documented to have cement PE by chest CT. Cement PE was detected in only 17% (4/23) of patients on the initial reading of the CT scan.

Discussion

In the current study, we found, among a large cohort of patients undergoing vertebroplasty, a relatively high incidence of small asymptomatic cement PEs. Notably, operators identified migration of cement to the lungs during the vertebroplasty procedure in only a small minority of patients with cement PE. Indeed, operators failed to detect any type of extravertebral leakage in more than one-half of patients who had cement emboli. These findings suggest that even for practitioners highly experienced in vertebroplasty, cement PEs are not only common but are commonly unrecognized.

Previous studies have found the incidence of cement PE to range from 2.1% to 26%.14 As in the current study, patients in those other series typically remained asymptomatic. However, even small emboli may be lethal if they lodge in the right atrium or ventricle and cause cardiac perforation and cardiac tamponade rather than traveling to the pulmonary circulation. Linear pieces of cement as small as 10–20 mm long have been reported to cause cardiac tamponade,29 and pieces as small as 20 mm have been reported to cause perforations of the right ventricle.3032 Thus, the observation of low rates of symptoms in our current series and other recent publications should not indicate that these frequent complications are necessarily benign.

Those with cement PE were significantly younger than those without, a finding for which we have no definitive explanation. As might be expected, patients with cement PE had significantly more total levels treated than patients without cement PE. There was a trend toward a lesser volume of cement used per level in the patients with cement PE. One explanation for this trend might be that extraosseous leakage would have led to early cessation of cement infusion, but most of the patients who had cement PE did not have leakage noted by the operator during the procedure.

Given the large variation in vertebroplasty cement mixtures available today, there may be a significant difference in rates of cement PE among various types. Studies comparing the types of cement may be useful.

Our study offers complementary and additive information to that of Kim et al4 in that we included nearly 4 times as many patients. However, being retrospective, this study had several limitations. There was some selection bias due to the fact that only a minority of patients subsequently had chest CTs. It may be presumed that those symptomatic patients would be more likely to undergo chest CT. Thus, cement PE may be over-represented in this population. Second, there was no uniform timeframe between vertebroplasty and CT. Nevertheless, the permanence of cement emboli allows variance in follow-up times. Many patients had multiple vertebroplasty procedures, and with 1 chest CT, it was not possible to detect during which session and in which levels the embolization occurred. We also could not control for chest CT technique, including image section thickness and administration of contrast. However, the focus of this article was not the relative accuracy of CT with and without contrast for cement PE detection but rather our best effort to determine, in a large series of patients, the approximate proportion of patients undergoing vertebroplasty who have cement PEs.

Conclusions

In this study, we found, among a large cohort of patients who underwent vertebroplasty, a high incidence of small asymptomatic cement PEs. In most cases, operators failed to identify extravertebral cement leakage during the procedure.

Acknowledgments

We thank Leigh A. Gray for advice regarding patient data collection and manuscript preparation.

Abbreviations

CI

confidence interval

IV

intravenous

MIP

maximum intensity projection

PE

pulmonary embolism

PMMA

polymethylmethacrylate

References

  • 1. Choe DH, Marom EM, Ahrar K, et al. Pulmonary embolism of polymethyl methacrylate during percutaneous vertebroplasty and kyphoplasty. AJR Am J Roentgenol 2004;183:1097–102 [DOI] [PubMed] [Google Scholar]
  • 2. Venmans A, Lohle PN, van Rooij WJ, et al. Frequency and outcome of pulmonary polymethylmethacrylate embolism during percutaneous vertebroplasty. AJNR Am J Neuroradiol 2008;29:1983–85 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Venmans A, Klazen CA, Lohle PN, et al. Percutaneous vertebroplasty and pulmonary cement embolism: results from VERTOS II. AJNR Am J Neuroradiol 2010;31:1451–3.Epub 2010 May 20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Kim YJ, Lee JW, Park KW, et al. Pulmonary cement embolism after percutaneous vertebroplasty in osteoporotic vertebral compression fractures: incidence, characteristics, and risk factors. Radiology 2009;251:250–59 [DOI] [PubMed] [Google Scholar]
  • 5. Dansie DM, Luetmer PH, Lane JI, et al. MRI findings after successful vertebroplasty. AJNR Am J Neuroradiol 2005;26:1595–600 [PMC free article] [PubMed] [Google Scholar]
  • 6. Gray LA, Rad AE, Gaughen JR, Jr, et al. Efficacy of percutaneous vertebroplasty for multiple synchronous and metachronous vertebral compression fractures. AJNR Am J Neuroradiol 2009;30:318–22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Hunt CH, Kallmes DF, Thielen KR. A unilateral vertebroplasty approach using a curved injection cannula for directed, site-specific vertebral body filling. J Vasc Interv Radiol 2009;20:553–55 [DOI] [PubMed] [Google Scholar]
  • 8. Kallmes DF. Randomized vertebroplasty trials: current status and challenges. Acad Radiol 2006;13:546–49 [DOI] [PubMed] [Google Scholar]
  • 9. Kallmes DF. Percutaneous vertebroplasty causing an increase in retropulsion of bone fragments. J Vasc Interv Radiol 2007;18:1333–34 [DOI] [PubMed] [Google Scholar]
  • 10. Kallmes DF, Comstock BA, Gray LA, et al. Baseline pain and disability in the investigational vertebroplasty efficacy and safety trial. AJNR Am J Neuroradiol 2009;30:1203–05 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Kaufmann TJ, Trout AT, Kallmes DF. The effects of cement volume on clinical outcomes of percutaneous vertebroplasty. AJNR Am J Neuroradiol 2006;27:1933–37 [PMC free article] [PubMed] [Google Scholar]
  • 12. Kaufmann TJ, Wald JT, Kallmes DF. A technique to circumvent subcutaneous cement tracts during percutaneous vertebroplasty. AJNR Am J Neuroradiol 2004;25:1595–96 [PMC free article] [PubMed] [Google Scholar]
  • 13. Kearns AE, Kallmes DF. Osteoporosis primer for the vertebroplasty practitioner: expanding the focus beyond needles and cement. AJNR Am J Neuroradiol 2008;29:1816–22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Knavel EM, Rad AE, Thielen KR, et al. Clinical outcomes with hemivertebral filling during percutaneous vertebroplasty. AJNR Am J Neuroradiol. 2009;30:496–99.Epub 2009 Jan 15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Knavel EM, Thielen KR, Kallmes DF. Vertebroplasty for the treatment of traumatic nonosteoporotic compression fractures. AJNR Am J Neuroradiol 2009;30:323–27 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Koch CA, Layton KF, Kallmes DF. Outcomes of patients receiving long-term corticosteroid therapy who undergo percutaneous vertebroplasty. AJNR Am J Neuroradiol 2007;28:563–66 [PMC free article] [PubMed] [Google Scholar]
  • 17. Lane JI, Maus TP, Wald JT, et al. Intravertebral clefts opacified during vertebroplasty: pathogenesis, technical implications, and prognostic significance. AJNR Am J Neuroradiol 2002;23:1642–46 [PMC free article] [PubMed] [Google Scholar]
  • 18. Layton KF, Thielen KR, Koch CA, et al. Vertebroplasty, first 1000 levels of a single center: evaluation of the outcomes and complications. AJNR Am J Neuroradiol 2007;28:683–89 [PMC free article] [PubMed] [Google Scholar]
  • 19. Lehman VT, Gray LA, Kallmes DF. Percutaneous vertebroplasty for painful compression fractures in a small cohort of patients with a decreased expectation-related placebo effect due to dementia. AJNR Am J Neuroradiol 2008;29:1461–64 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. McDonald RJ, Trout AT, Gray LA, et al. Vertebroplasty in multiple myeloma: outcomes in a large patient series. AJNR Am J Neuroradiol 2008;29:642–48 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Rad AE, Gray LA, Kallmes DF. Significance and targeting of small, central clefts in severe fractures treated with vertebroplasty. AJNR Am J Neuroradiol 2008;29:1285–87 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Rad AE, Kallmes DF. Pain relief following vertebroplasty in patients with and without localizing tenderness on palpation. AJNR Am J Neuroradiol 2008;29:1622–26 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Trout AT, Gray LA, Kallmes DF. Vertebroplasty in the inpatient population. AJNR Am J Neuroradiol 2005;26:1629–33 [PMC free article] [PubMed] [Google Scholar]
  • 24. Trout AT, Kallmes DF. Does vertebroplasty cause incident vertebral fractures? A review of available data. AJNR Am J Neuroradiol 2006;27:1397–403 [PMC free article] [PubMed] [Google Scholar]
  • 25. Trout AT, Kallmes DF, Gray LA, et al. Evaluation of vertebroplasty with a validated outcome measure: the Roland-Morris Disability Questionnaire. AJNR Am J Neuroradiol 2005;26:2652–57 [PMC free article] [PubMed] [Google Scholar]
  • 26. Trout AT, Kallmes DF, Kaufmann TJ. New fractures after vertebroplasty: adjacent fractures occur significantly sooner. AJNR Am J Neuroradiol 2006;27:217–23 [PMC free article] [PubMed] [Google Scholar]
  • 27. Trout AT, Kallmes DF, Lane JI, et al. Subsequent vertebral fractures after vertebroplasty: association with intraosseous clefts. AJNR Am J Neuroradiol 2006;27:1586–91 [PMC free article] [PubMed] [Google Scholar]
  • 28. Trout AT, Kallmes DF, Layton KF, et al. Vertebral endplate fractures: an indicator of the abnormal forces generated in the spine after vertebroplasty. J Bone Miner Res 2006;21:1797–802 [DOI] [PubMed] [Google Scholar]
  • 29. Caynak B, Onan B, Sagbas E, et al. Cardiac tamponade and pulmonary embolism as a complication of percutaneous vertebroplasty. Ann Thorac Surg 2009;87:299–301 [DOI] [PubMed] [Google Scholar]
  • 30. Monticelli F, Meyer HJ, Tutsch-Bauer E. Fatal pulmonary cement embolism following percutaneous vertebroplasty (PVP). Forensic Sci Int 2005;149:35–38 [DOI] [PubMed] [Google Scholar]
  • 31. Yoo KY, Jeong SW, Yoon W, et al. Acute respiratory distress syndrome associated with pulmonary cement embolism following percutaneous vertebroplasty with polymethylmethacrylate. Spine (Phila Pa 1976) 2004;29:E294–97 [DOI] [PubMed] [Google Scholar]
  • 32. Stricker K, Orler R, Yen K, et al. Severe hypercapnia due to pulmonary embolism of polymethylmethacrylate during vertebroplasty. Anesth Analg 2004;98:1184–86 [DOI] [PubMed] [Google Scholar]

Articles from AJNR: American Journal of Neuroradiology are provided here courtesy of American Society of Neuroradiology

RESOURCES